isoxazoles has been researched along with Mental Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takechi, K | 1 |
| Hwang, TJ; Jafarov, A; Jakubowiak, W; Keshavjee, S; Nunn, P; Wares, DF | 1 |
| Cavanna, AE; Seri, S | 1 |
| Hiramatsu, M | 1 |
| Pairas, GN; Perperopoulou, F; Tsoungas, PG; Varvounis, G | 1 |
| Darby, JK; Herbert, J; Pasta, DJ; Wilson, MG | 1 |
| Barbe, R; Bertschy, G; Bryois, C; Gervasoni, N | 1 |
| Charles, B; Dean, AJ; Jones, T; McDermott, BM; Norris, R; Van Breda, K | 1 |
| Fukui, N; Inoue, Y; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Beniak, TE; Birnbaum, AK; Leppik, IE; Marino, SE; Walczak, TS; White, JR | 1 |
| Cao, F; Dirani, R; Halpern, R; Panish, JM | 1 |
| Calarge, CA; Miller, del D | 1 |
| Cincotta, M; Tramacere, L; Zaccara, G | 1 |
| Han, C; Joe, SH; Ko, YH; Lee, MS; Lim, J; Yang, J | 1 |
| Aman, MG; Bies, RR; Saldaña, SN; Sherwin, CM; Vinks, AA | 1 |
| Ohtahara, S; Yamatogi, Y | 2 |
| Aman, MG; Lindsay, RL; Malone, K; Mannaert, E; Masty, J; Ramadan, Y; Remmerie, B; Vinks, AA | 1 |
| Kaleyias, J; Kothare, SV | 1 |
| Casey, DE; Gerlach, J; Hetmar, O; Kaldan, B; Korsgaard, S; Mikkelsen, LB | 1 |
| Post, L | 1 |
| Buttiëns, M; Dierick, G; Geutjens, J; Heylen, S; Sieben, G; Thiry, P; Vanden Borre, R; Vermote, R | 1 |
| Ozawa, H; Sasaki, M; Sugai, K; Yano, H | 1 |
| Bork, JA; de Leon, J; Rogers, T; Wedlund, PJ | 1 |
6 review(s) available for isoxazoles and Mental Disorders
| Article | Year |
|---|---|
[Neurobehavioral Comorbidities in Pentylenetetrazol-kindled Mice and Role of the α4β2 Nicotinic Acetylcholine Receptor].
Topics: Animals; Cell Adhesion Molecules, Neuronal; Disease Models, Animal; Down-Regulation; Epilepsy; Isoxazoles; Kindling, Neurologic; Membrane Proteins; Mental Disorders; Mice; Nerve Tissue Proteins; Pentylenetetrazole; Piriform Cortex; Psychomotor Performance; Pyrrolidines; Quality of Life; Receptors, Nicotinic; Seizures; Social Behavior | 2019 |
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
Topics: Antibiotics, Antitubercular; Central Nervous System Diseases; Cycloserine; Humans; Isoxazoles; Mental Disorders; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
[Functional role for GABA transporters in the CNS].
Topics: Animals; Brain; Camphanes; Carbazoles; Carrier Proteins; Central Nervous System Diseases; Drug Discovery; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; Humans; Isoxazoles; Mental Disorders; Molecular Targeted Therapy; Nipecotic Acids; Piperidines; Tiagabine | 2014 |
The Isoxazole Ring and Its N-Oxide: A Privileged Core Structure in Neuropsychiatric Therapeutics.
Topics: Blood-Brain Barrier; Drug Design; Humans; Isoxazoles; Mental Disorders; Nitrogen; Oxides; Psychotropic Drugs; Receptors, Cytoplasmic and Nuclear | 2017 |
Drug safety evaluation of zonisamide for the treatment of epilepsy.
Topics: Animals; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Isoxazoles; Kidney Calculi; Mental Disorders; Randomized Controlled Trials as Topic; Zonisamide | 2011 |
Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
Topics: Analgesics, Non-Narcotic; Anticonvulsants; Brain Diseases; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Mental Disorders; Treatment Outcome; Zonisamide | 2008 |
4 trial(s) available for isoxazoles and Mental Disorders
| Article | Year |
|---|---|
Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients.
Topics: Adult; Aged; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sex Characteristics; Tandem Mass Spectrometry; Young Adult | 2010 |
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
Topics: Adolescent; Antipsychotic Agents; Area Under Curve; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Developmental Disabilities; Female; Genotype; Half-Life; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Pyrimidines; Risperidone; Saliva | 2007 |
The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
Topics: Adult; Aged; Analgesics; Antipsychotic Agents; Blinking; Clinical Trials as Topic; Confusion; Dizziness; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Oxazoles; Parkinson Disease, Secondary; Placebos; Vomiting | 1982 |
Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Isoxazoles; Male; Mental Disorders; Middle Aged; Piperidines; Placebos; Risperidone | 1993 |
14 other study(ies) available for isoxazoles and Mental Disorders
| Article | Year |
|---|---|
Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Electroencephalography; Epilepsy; Female; Humans; Isoxazoles; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Psychotic Disorders; Zonisamide | 2013 |
Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antipsychotic Agents; Benzodiazepines; Biotransformation; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Humans; Inpatients; Isoxazoles; Male; Mental Disorders; Middle Aged; Olanzapine; Paliperidone Palmitate; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia; Young Adult | 2008 |
[Psychiatry].
Topics: Antidepressive Agents; Antipsychotic Agents; Humans; Isoxazoles; Mental Disorders; Paliperidone Palmitate; Psychotherapy; Pyrimidines | 2009 |
Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders.
Topics: Adolescent; Antipsychotic Agents; Child; Chromatography, High Pressure Liquid; Female; Humans; Isoxazoles; Linear Models; Male; Mental Disorders; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity | 2009 |
Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.
Topics: Adult; Anticonvulsants; Case-Control Studies; Cognition Disorders; Epilepsy; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Retrospective Studies; Risk Factors; Young Adult; Zonisamide | 2010 |
Exploratory analysis of psychiatric-related utilization and costs associated with paliperidone ER compared with other oral atypical antipsychotics using pharmacy claims from an administrative database.
Topics: Adult; Antipsychotic Agents; Comorbidity; Delayed-Action Preparations; Emergency Service, Hospital; Female; Health Expenditures; Health Services; Humans; Insurance Claim Review; Isoxazoles; Male; Mental Disorders; Middle Aged; Paliperidone Palmitate; Patient Admission; Pyrimidines; Retrospective Studies; Socioeconomic Factors; United States | 2010 |
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.
Topics: Adolescent; Aging; Antipsychotic Agents; Body Mass Index; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Polypharmacy; Psychotic Disorders; Pyrimidines; Risperidone; Sex Factors; Sexual Development | 2011 |
Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients.
Topics: Adult; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Outpatients; Overweight; Psychotropic Drugs; Severity of Illness Index; Treatment Outcome; Weight Gain; Weight Loss; Zonisamide | 2011 |
Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Child; Child, Preschool; Cohort Studies; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Phenotype; Prospective Studies; Pyrimidines; Risperidone | 2012 |
Safety of zonisamide therapy: prospective follow-up survey.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Infant; Isoxazoles; Male; Mental Disorders; Middle Aged; Product Surveillance, Postmarketing; Zonisamide | 2004 |
Erratum to "Safety of zonisamide therapy: prospective follow-up survey.".
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Infant; Isoxazoles; Male; Mental Disorders; Middle Aged; Product Surveillance, Postmarketing; Zonisamide | 2007 |
Risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Community Mental Health Services; Humans; Isoxazoles; Mental Disorders; Piperidines; Risperidone | 1994 |
[A case of behavior disorder with gait and sleep disturbances induced by zonisamide].
Topics: Anticonvulsants; Child; Female; Gait; Humans; Isoxazoles; Mental Disorders; Sleep Wake Disorders; Zonisamide | 1995 |
A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
Topics: Adolescent; Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Oxidoreductases, N-Demethylating; Paliperidone Palmitate; Pilot Projects; Pyrimidines; Risperidone | 1999 |